Trial intelligence / Profile preview

Nabilone for chronic daily headache in medication overuse headache non-responders

2007-007873-22Phase 2Completed

Sponsor
AOU Policlinico di Modena
Start
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of nabilone in medication overuse headache (MOH) and chronic daily headache (CDH) (2 arms), sponsored by AOU Policlinico di Modena. Primary endpoints: Safety and tolerability of nabilone and Reduction in analgesic consumption. Started Dec 2007; status: completed.

02

Drugs

nabilone
03

Conditions

medication overuse headache (MOH)chronic daily headache (CDH)

Beyond the preview

Go deeper on 2007-007873-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-007873-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call